{{ $DoctorName }} @if (isset(session()->get('doctor')['vCentralCode'])) {{ session()->get('doctor')['vCentralCode'] }} @endif
@if (isset(session()->get('doctor')['vCentralCode']))
Logout
@endif

{{ $ActivityTypeName }}

{{ $ActivityName }}

@csrf
@if (isset(session()->get('doctor')['vCentralCode']))
Back
@else
@endif

Natural Micronised Progesterone (NMP) including Oral NMP SR formulation Survey in Threatened Abortion & Recurrent Pregnancy Loss (RPL)

  1. What proportion of patients of threatened abortion do you usually see in your clinical practice in a month? *

  2. Gestational age in the most of the patients with threatened abortion is _____? *

  3. Which of the following symptoms are most common in patients with threatened abortion? *

  4. In how many percentages of threatened abortion patients do you measure serum progesterone level? *
    5. % of patients
  5. Which route of administration is most preferred by threatened abortion patients? *

  6. Oral progesterone formulation is prescribed in how many percentages of threatened abortion patients? *

  7. Vaginal progesterone formulation (Gel/Capsule) is prescribed in how many percentages of threatened abortion patients? *

  8. In your practice, which of the following molecule/s do you prefer most for threatened abortion treatment? *

  9. In your practice, which formulation & route of natural micronized progesterone do you prefer most? *

  10. How will you rate the effectiveness of NMP-SR (Sustained Release) preparation? *

  11. How will you rate the compliance of NMP-SR (Sustained Release) preparation compared to vaginal progesterone preparation? *

  12. With Oral NMP capsule, how many percentage of patients complaint about sedation/dizziness? *

  13. Due to sustained release property, Oral NMP SR minimizes first pass metabolism, how many percentages of patient complaint about sedation/dizziness with oral NMP SR formulation? *

  14. Which strength of oral NMP SR do you prefer most for threatened abortion patients? *

  15. Which dosage frequency of oral NMP SR do you prefer most for threatened abortion patients? *

  16. Generally, till how many weeks of gestation do you continue with progesterone support in patients with threatened abortion? *

  17. In how many percentages of patients, do you check fetal heart rate at diagnosis of threatened abortion? *
    18. 1

    2

    3

    % of patients
  18. In how many percentages of threatened abortion patient who are on progesterone support continue to have pregnancy beyond 16 weeks of gestation? *

  19. In your clinical practice, for which of the following reasons do you prefer NMP sustained release preparation? *

  20. How do you rate the immunomodulatory property of NMP for Threatened Abortion?*

  21. Most of the patients with threatened abortion are in early pregnancy hence, safety of molecule used in treatment is very crucial. Which of the following molecules is the safest to use in pregnancy?*

  22. In your practice, which of the following molecule/s do you prefer most for patients with recurrent pregnancy loss?*

  23. In your practice, till how many weeks of gestation do you usually give treatment with NMP in recurrent pregnancy loss?*

  24. How do you rate the immunomodulatory role of NMP in recurrent pregnancy loss?*

  25. Do you routinely test for inflammatory markers in patients with recurrent pregnancy loss?*